AzTrials
AzTrials

Well-Being, PsychologicalNCT07331922

Mental Health App and Impact on Wellbeing

A study testing mental health app in people with Well-Being, Psychological, run by Penn State University at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if intervention with Landing Place mental health app can support wellness in college students. The main questions it aims to answer are: Can the app increased well-being in college students? Will the app have increased use and usability by the college students? Researchers… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Well-Being, Psychological
What is being tested?
mental health app
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteUnited States
Study dates
Aug 2026to May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Penn State Behrend students
  • Over the age of 18
  • Must have an iPhone

Who cannot join

  • People outside of Penn State
  • Minors
  • People currently in therapy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christopher R Shelton, PhD contact

814-898-6082

cshelton@psu.edu

United States1 site
  • PennState the Beherend College/VAR Lab

    Erie, Pennsylvania, 16563

    Christopher R Shelton, PhD, : 814-898-6082, cshelton@psu.edu

Other trials in United States

About this study

Official title: Landing Place: Impact of the Landing Place Mental Health App on Mental Health and Well-being

The goal of this clinical trial is to learn if intervention with Landing Place mental health app can support wellness in college students. The main questions it aims to answer are:

Can the app increased well-being in college students? Will the app have increased use and usability by the college students? Researchers will compare two groups of participants to see if the app intervention will increase wellbeing and app usability rates.

Participants will randomly assigned into group 1 and 2. Group 1 will not use the app at all. Group 2 will use the app almost every day for 4 weeks.

Read the detailed description

Mental health concerns across the United States have increased substantially, affecting individuals across age groups, geographic regions, and socioeconomic backgrounds. Emerging adults demonstrate the highest prevalence of mental health conditions among adult populations, while simultaneously exhibiting the lowest rates of treatment utilization. Barriers to treatment for this population include limited affordability, accessibility, availability, and acceptability of mental health services.

Digital mental health interventions have demonstrated effectiveness across a range of outcomes, including symptom reduction, self-management, and well-being enhancement. Smartphone-based applications, in particular, have been evaluated as tools to integrate mental health support through scalable and accessible technologies. Such applications may offer features including guided self-help activities, mindfulness practices, journaling, mood tracking, psychoeducational content, and location-based resources for mental health services.

Following the COVID-19 pandemic, mental health challenges among U.S. college students have intensified, with documented impacts on academic performance and overall functioning. These challenges are further exacerbated by stigma, financial constraints, and limited access to campus-based or community mental health services, particularly for students from historically marginalized backgrounds.

In response to these needs, Penn State Behrend's Virtual/Augmented Reality (VAR) Lab developed the Landing Place mental health app, a free digital intervention designed to support mental wellness among college students in the Erie region. The application was developed with an emphasis on usability, privacy, and accessibility, and is tailored to the developmental and contextual needs of young adults. Planned future iterations of the application aim to extend its use to additional populations, such as survivors of domestic violence.

The Landing Place app incorporates artificial intelligence, supported features and evidence-based therapeutic components, including mindfulness exercises, goal-setting activities, journaling, mood tracking, and educational content related to mental health and coping strategies. This clinical trial evaluates the effectiveness, usability, and acceptability of the application when used as a self-guided mental wellness intervention among college students.

The study examines multiple forms of data, including behavioral change measures, user engagement metrics, usability assessments, and participant feedback, to assess the app's utility in supporting well-being. It is hypothesized that participants who use the application will demonstrate increased well-being compared to a control group, along with higher engagement and acceptability of the app-based intervention modality.

Being tested
mental health app
Keywords
Digital Mental Health, College Students, Well-being
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mental health appBehavioural

    The intervention will be the use of an AI-powered mental health app that includes activities based on evidence-based therapeutic techniques, mindfulness, goal setting, journaling, mood tracking, and educational material. The app is secure, easy-to-use, and customized for the needs of the college students.

Study groups in NCT07331922
Study groupRoleWhat they receive
Control GroupNo interventionGroup 1 will not use the app at all.
App-intervention groupExperimentalGroup 2 will use the mental health app almost every day for 4 weeks. The following activities must be completed in-app by participants in this arm: * Cognitive exercise (2 per week) * Mindfulness (2 per week) * Mood tracker (4 per week) * Chat feature (2 per week) * Articles (3 across the 4 weeks) * Journal (3 across the 4 weeks) * To-do (related to the goal, once a week) * Goals (1 goal at the beginning)
Receives: Behavioral: mental health app

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Well-being related to Attention and Cognitive Functioning

    Attention-related symptoms will be assessed using the DSM-5-TR Attention-Deficit/Hyperactivity Disorder and Sluggish Cognitive Tempo Measure, a self-report scale evaluating attentional functioning. Scores vary by subscale, with higher scores indicating greater symptom severity.

    Measured: From enrollment to the end of intervention at 5 weeks

  2. Well-being related to Health-related quality of life

    Health-related quality of life will be measured using the Medical Outcomes Study Short Form-36 Health Survey (SF-36). The instrument generates domain scores ranging from 0 to 100, with higher scores indicating better perceived health and well-being.

    Measured: From enrollment to the end of the intervention at 5 weeks

  3. Well-being related to Mental Health Symptom Severity

    Mental health symptom severity will be assessed using the Depression Anxiety Stress Scales - 21 Items (DASS-21), a self-report instrument measuring symptoms of depression, anxiety, and stress. Scores range from 0 to 63, with higher scores indicating greater symptom severity.

    Measured: From enrollment to the end of the intervention at 5 weeks

  4. Well-being related to Functional Impairment

    Functional impairment will be evaluated using the Brief Functional Impairment Scale - Long Form (BFIS-LF), which assesses impairment across daily functioning domains. Scores range from 0 to 100, with higher scores indicating greater functional impairment.

    Measured: From enrollment to the end of the intervention at 5 weeks

Secondary outcomes (3)
  1. Usability

    App usability will be assessed using the mHealth App Usability Questionnaire - Standalone Patient App Version (MAUQ-SPA), a self-report instrument designed to evaluate the usability of standalone mHealth applications. Items are rated on a 7-point Likert scale, and total scores range from 1 to 7, with higher scores indicating better perceived usability.

    Measured: From enrollment to the end of treatment at 5 weeks

  2. Usage

    Patterns of mobile health application use will be assessed using the mHealth Usage Questionnaire, a self-report measure evaluating frequency and duration of app use. Scores are reported in units on a scale, with higher scores indicating greater application use.

    Measured: From enrollment to the end of the intervention at 5 weeks

  3. Engagement

    Engagement with mobile health technology will be measured using the mHealth Technology Use Questionnaire, which assesses overall use and engagement with mHealth technologies. Scores are reported in units on a scale, with higher scores indicating greater technology engagement.

    Measured: From enrollment to the end of the intervention at 5 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2026
  2. Study startAug 2026 (estimated)
  3. Primary completionMay 2027 (estimated)
  4. Study completionMay 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07331922
Sponsor's protocol ID
STUDY00024830
Status last verified
May 2026
First submitted
18 Dec 2025
Last updated
6 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Andersson, G., & Titov, N. (2014). Advantages and limitations of Internet-based interventions for common mental disorders. World Psychiatry; Official Journal of the World Psychiatric Association (WPA), 13(1), 4-11. doi:10.1002/wps.20083 PMID:24497236 Barak, A., Hen, L., Boniel-Nissim, M., & Shapira, N. (2008). A comprehensive review and a meta-analysis of the effectiveness of internet-based psychotherapeutic interventions. Journal of Technology in Human Services, 26(2-4), 109-160. doi:10.1080/15228830802094429 Boggs, J. M., Beck, A., Felder, J. N., Dimidjian, S., Metcalf, C. A., & Segal, Z. V. (2014). Web-Based Intervention in Mindfulness Meditation for Reducing Residual Depressive Symptoms and Relapse Prophylaxis: A Qualitative Study. Journal of Medical Internet Research, 16(3), e87. doi:10.2196/jmir.3129 PMID:24662625 Hedman, E., El Alaoui, S., Lindefors, N., Andersson, E., Rück, C., Ghaderi, A., Kaldo, V., Lekander, M., Andersson, G., & Ljótsson, B. (2014). Clinical effectiveness and cost-effectiveness of Internet- vs. group-based cognitive behavior therapy for social anxiety disorder: 4-year follow-up of a randomized trial. Behaviour Research and Therapy, 59, 20-29. doi:10.1016/j.brat.2014.05.010 PMID:24949908 Luxton, D. D., McCann, R. A., Bush, N. E., Mishkind, M. C., & Reger, G. M. (2011). mHealth for mental health: Integrating smartphone technology in behavioral healthcare. Professional Psychology, Research and Practice, 42(6), 505-512. doi:10.1037/a0024485 Proudfoot, J. G. (2004). Computer-based treatment for anxiety and depression: Is it feasible? Is it effective? Neuroscience and Biobehavioral Reviews, 28(3), 353-363. doi:10.1016/j.neubiorev.2004.03.008 PMID:15225977 Substance Abuse and Mental Health Services Administration. (2017). Key substance use and mental health indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral

Questions about this trial

What is this clinical trial studying?

A study testing mental health app in people with Well-Being, Psychological, run by Penn State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christopher R Shelton, PhD (814-898-6082, cshelton@psu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Well-being related to Attention and Cognitive Functioning (time frame: From enrollment to the end of intervention at 5 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07331922, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in